ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogsBruce W. Keene, Masami Uechi, Clarke E. Atkins et al.|Journal of Veterinary Internal Medicine|2019Cited by 810
Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart DiseaseClarke E. Atkins, Rebecca L. Stepien, S. Ettinger et al.|Journal of Veterinary Internal Medicine|2009Cited by 545
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical TrialAdrian Boswood, Philip Watson, Jens Häggström et al.|Journal of Veterinary Internal Medicine|2016Cited by 318
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL StudyPhilip R. Fox, Marie de Swarte, Bruce W. Keene et al.|Journal of Veterinary Internal Medicine|2018Cited by 152
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC StudyAdrian Boswood, Philip Watson, Sonya G. Gordon et al.|Journal of Veterinary Internal Medicine|2017Cited by 78